{
 "PrintNo":"A705","Version":"B","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2020-12-30T11:52:39.86789Z","Status":"IN_ASSEMBLY_COMM","Committee":"Ways And Means",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-04-27","Committee":"Ways And Means"}],
 "Actions":[
  {"Text":"REFERRED TO ALCOHOLISM AND DRUG ABUSE","Date":"2021-01-06","Chamber":"ASSEMBLY"},
  {"Text":"AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE","Date":"2021-05-13","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 705A","Date":"2021-05-13","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"REPORTED REFERRED TO WAYS AND MEANS","Date":"2021-05-24","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"REFERRED TO WAYS AND MEANS","Date":"2022-01-05","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"AMEND AND RECOMMIT TO WAYS AND MEANS","Date":"2022-04-27","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"PRINT NUMBER 705B","Date":"2022-04-27","Chamber":"ASSEMBLY","Version":"B"}
 ],
 "Votes":[
  {
   "VoteType":"Favorable refer to committee Ways and Means","Date":"1969-12-31","Chamber":"ASSEMBLY",
   "Votes":[
    {"ID":675,"Short":"STECK","Vote":"Aye"},{"ID":1461,"Short":"BROWN","Vote":"Aye"},
    {"ID":618,"Short":"QUART","Vote":"Aye"},{"ID":1238,"Short":"DESTEFANO","Vote":"Aye"},
    {"ID":571,"Short":"STIRPE","Vote":"Aye"},{"ID":1466,"Short":"DURSO","Vote":"Aye"},
    {"ID":655,"Short":"DAVILA","Vote":"Aye"},{"ID":1465,"Short":"GANDOLFO","Vote":"Aye"},
    {"ID":662,"Short":"MCDONALD","Vote":"Aye"},{"ID":1146,"Short":"FERNANDEZ","Vote":"Aye"},
    {"ID":1241,"Short":"GRIFFIN","Vote":"Aye"},{"ID":1257,"Short":"REYES","Vote":"Aye"},
    {"ID":1471,"Short":"GALLAGHER","Vote":"Aye"},{"ID":1476,"Short":"JACKSON","Vote":"Aye"}
   ]
  }
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Relates to the availability of buprenorphine in opioid treatment programs",
 "Summary":"Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.",
 "LawSection":"Mental Hygiene Law","LawCode":"Add ยง32.12, Ment Hyg L",
 "ActClause":"AN ACT to amend the mental hygiene law, in relation to the availability of buprenorphine in opioid treatment programs",
 "SameAsPrintNo":"S6746-2021","PreviousVersions":["A5953-2019"]
}